| Balance Sheets | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 90 | 132 | 223 | 12,952 |
| Accounts receivable | 1,266 | 21,811 | 8,966 | 6,380 |
| Related-party receivables | 0 | 0 | 9,155 | 9,155 |
| Other current assets | 188 | 188 | 598 | 598 |
| Total current assets | 1,544 | 22,131 | 18,942 | 29,085 |
| Right-of-use asset | 0 | 0 | 0 | 2,795 |
| Total assets | 1,544 | 22,131 | 18,942 | 31,880 |
| Accounts payable and accrued expenses | 190,467 | 159,116 | 101,297 | 100,343 |
| Bank overdraft | NaN | NaN | NaN | 0 |
| Deferred revenues | NaN | NaN | 12,000 | NaN |
| Credit cards | 30,327 | 30,327 | 30,327 | 30,327 |
| Accrued interest | 26,773 | 26,773 | 22,095 | 22,095 |
| Related-party payables | 845,294 | 793,196 | 717,275 | 623,474 |
| Short-term loans (net of amortization of loan fees) | 111,721 | 111,721 | 111,721 | 111,722 |
| Sba loans | 14,592 | 14,592 | 14,592 | 14,592 |
| Derivative liabilities | 0 | 0 | 0 | 29,322 |
| Lease liabilities | 0 | 0 | 0 | 4,906 |
| Convertible note | 0 | 101 | 6,363 | 9,182 |
| Total current liabilities | 1,219,174 | 1,135,826 | 1,015,670 | 945,963 |
| Notes payable | NaN | NaN | NaN | 0 |
| Sba loans | 249,500 | 249,500 | 249,500 | 249,500 |
| Lease liabilities | NaN | NaN | NaN | 0 |
| Total long-term liabilities | 249,500 | 249,500 | 249,500 | 249,500 |
| Total liabilities | 1,468,674 | 1,385,326 | 1,265,170 | 1,195,463 |
| Authorized 10,000,000 shares of preferred stock, without par value, of which 2,500,000 shares have been designated series a convertible preferred stock (2,500,000 shares outstanding at february 28, 2026, and may 31, 2025) and 2,000 shares have been designated series b preferred stock (2,000 shares outstanding at february 28, 2026, and may 31, 2025) | 0 | 0 | 0 | 0 |
| Common stock, without par value 20,000,000,000 shares authorized, of which 11,626,749,347 shares were issued and outstanding at february 28, 2026, and may 31, 2025 | 0 | 0 | 0 | 0 |
| Additional paid-in capital | 4,719,318 | 4,719,318 | 4,719,318 | 4,719,318 |
| Accumulated deficit | -6,186,448 | -6,082,513 | -5,965,546 | -5,882,901 |
| Total stockholders deficiency | -1,467,130 | -1,363,195 | -1,246,228 | -1,163,583 |
| Total liabilities and stockholders deficiency | 1,544 | 22,131 | 18,942 | 31,880 |
Cannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. (CBIH)